Nonalcoholic Steatohepatitis is the Most Rapidly Increasing Indication for Liver Transplantation in the United States

Hepatology

Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Implications for liver transplantation

Liver Transpl

Younossi ZM

doi: 10.1002/lt.25003.

Hepatology

Longitudinal Correlations Between MRE, MRI-PDFF, and Liver Histology in Patients with Nonalcoholic Steatohepatitis: Analysis of Data from a Phase 2 Trial of Selonsertib

J Hepatol.

Jayakumar S, Middleton MS, Lawitz EJ, Mantry PS, Caldwell SH, Arnold H, Diehl AM, Ghalib R, Elkhashab M, Abdelmalek MF, Kowdley KV, Djedjos CS, Xu R, Han L, Subramanian GM, Myers RP, Goodman ZD, Afdhal NH, Charlton MR, Sirlin CB, Loomba R

doi: 10.1016/j.jhep.2018.09.024.

Hepatology

Stabilisation of acute-on-chronic liver failure patients before liver transplantation predicts post-transplant survival

Aliment Pharmacol Ther.

Huebener P, Sterneck MR, Bangert K, Drolz A, Lohse AW, Kluge S, Fischer L, Fuhrmann V

doi: 10.1111/apt.14627.

Further Publications

National Trends and Waitlist Outcomes of Locoregional Therapy among Liver Transplant Candidates with Hepatocellular Carcinoma in the United States

Clin Gastroenterol Hepatol

Kwong AJ, Ghaziani TT, Yao F, Sze D, Mannalithara A, Mehta N

doi: 10.1016/j.cgh.2021.07.048

Hepatology

Nonalcoholic steatohepatitis (NASH) - current treatment recommendations and future developments

Z Gastroenterol.

Roeb E, Geier A

doi: 10.1055/a-

Further Publications

Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States

J Hepatol

Kim D, Konyn P, Sandhu KK, Dennis BB, Cheung AC, Ahmed A

doi: 10.1016/j.jhep.2021.07.035

Outcomes of left split graft transplantation in Europe: report from the European Liver Transplant Registry (ELTR)

Transpl Int.

Angelico R, Nardi A, Adam R, Nadalin S, Polak WG, Karam V, Troisi R, Muiesan P; European Liver, Intestine Transplant Association (ELITA)

doi: 10.1111/tri.13147.

Hepatology

NGM282 Improves Liver Fibrosis and Histology in 12 Weeks in Patients with Nonalcoholic Steatohepatitis

Hepatology.

Harrison SA, Rossi SJ, Paredes AH, Trotter JF, Bashir MR, Guy CD, Banerjee R, Jaros MJ, Owers S, Baxter BA, Ling L, DePaoli AM

doi: 10.1002/hep.30590.

Hepatology

Hepatic deficiency of augmenter of liver regeneration predisposes to nonalcoholic steatohepatitis and fibrosis

Hepatology.

Kumar S, Verma AK, Rani R, Sharma A, Wang J, Shah SA, Behari J, Salazar Gonzalez R, Kohli R, Gandhi CR

doi: 10.1002/hep.31167.

Related content

Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Implications for liver transplantation

Longitudinal Correlations Between MRE, MRI-PDFF, and Liver Histology in Patients with Nonalcoholic Steatohepatitis: Analysis of Data from a Phase 2 Trial of Selonsertib

Stabilisation of acute-on-chronic liver failure patients before liver transplantation predicts post-transplant survival

National Trends and Waitlist Outcomes of Locoregional Therapy among Liver Transplant Candidates with Hepatocellular Carcinoma in the United States

Nonalcoholic steatohepatitis (NASH) - current treatment recommendations and future developments

Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States

Outcomes of left split graft transplantation in Europe: report from the European Liver Transplant Registry (ELTR)

NGM282 Improves Liver Fibrosis and Histology in 12 Weeks in Patients with Nonalcoholic Steatohepatitis

Hepatic deficiency of augmenter of liver regeneration predisposes to nonalcoholic steatohepatitis and fibrosis